세계의 불안장애 및 우울증 치료 시장 규모, 점유율, 동향 분석 : 적응증별, 약제별, 유통 채널별, 지역별 전망과 예측(2024-2031년)

The Global Anxiety Disorders And Depression Treatment Market size is expected to reach $15.7 billion by 2031, rising at a market growth of 3.5% CAGR during the forecast period.

Anticonvulsants have been shown to help manage comorbid anxiety symptoms in patients with mood disorders. Their ability to address multiple aspects of a patient's condition makes them a valuable treatment option. Lower Risk of Traditional Antidepressant Side Effects: Some anticonvulsants have a more favourable side effect profile compared to certain antidepressants, particularly concerning issues like sexual dysfunction or weight gain, making them a preferred choice for some patients. Thus, the Anticonvulsants segment attained 6% revenue share in the market in 2023.

The increasing emphasis on preventive care and early intervention has significantly impacted the anxiety disorders and depression treatment market. By identifying mental health issues at an earlier stage, healthcare providers can initiate treatment before the conditions become severe.

Additionally, the growing number of individuals experiencing these conditions has created a significant demand for effective treatments, including medications, psychotherapy, and other therapeutic interventions. As more people seek help for anxiety and depression, the market for treatments continues to expand.

However, the high cost of advanced treatments and therapies for anxiety disorders and depression can limit access to care for many individuals. Not everyone has sufficient financial resources or comprehensive insurance coverage to afford these treatments. As a result, people who need advanced therapies may forego treatment or opt for less effective alternatives, which can negatively impact their health outcomes.

Indication Outlook

On the basis of indication, the market is segmented into depression and anxiety. The anxiety segment recorded 55% revenue share in the market in 2023. Anxiety disorders are among the most common mental health conditions globally. Conditions such as generalized anxiety disorder (GAD), panic disorder, and social anxiety disorder affect millions of people, driving significant demand for effective treatments.

Drug Outlook

Based on drugs, the market are divided into antidepressants, anxiolytics, anticonvulsants, noradrenergic agents, atypical antipsychotics. The atypical antipsychotics segment procured 24% revenue share in the market in 2023. Atypical antipsychotics can help manage both depressive and anxiety symptoms, as well as other symptoms like irritability and mood swings.

Distribution Channel Outlook

By distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies. In 2023, the retail pharmacies segment registered 55% revenue share in the market. Retail pharmacies are widely accessible, making it easy for patients to obtain their medications without visiting specialized clinics or hospitals.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 26% revenue share in the market. There has been a growing awareness and recognition of mental health issues across the Asia-Pacific region.

List of Key Companies Profiled

• Pfizer Inc.
• GlaxoSmithKline PLC (GSK)
• Merck & Co., Inc.
• Eli Lilly And Company
• AstraZeneca PLC
• Bristol-Myers Squibb Company
• Johnson & Johnson
• AbbVie Inc.
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited

Global Anxiety Disorders And Depression Treatment Market Report Segmentation

By Indication

• Anxiety
• Depression

By Drugs

• Antidepressants
• Anxiolytics
• Anticonvulsants
• Noradrenergic Agents
• Atypical Antipsychotics

By Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Anxiety Disorders And Depression Treatment Market, by Indication
  • 1.4.2 Global Anxiety Disorders And Depression Treatment Market, by Drugs
  • 1.4.3 Global Anxiety Disorders And Depression Treatment Market, by Distribution Channel
  • 1.4.4 Global Anxiety Disorders And Depression Treatment Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges
• 3.3 Porter Five Forces Analysis

Chapter 4. Global Anxiety Disorders And Depression Treatment Market by Indication

• 4.1 Global Anxiety Market by Region
• 4.2 Global Depression Market by Region

Chapter 5. Global Anxiety Disorders And Depression Treatment Market by Drugs

• 5.1 Global Antidepressants Market by Region
• 5.2 Global Anxiolytics Market by Region
• 5.3 Global Anticonvulsants Market by Region
• 5.4 Global Noradrenergic Agents Market by Region
• 5.5 Global Atypical Antipsychotics Market by Region

Chapter 6. Global Anxiety Disorders And Depression Treatment Market by Distribution Channel

• 6.1 Global Retail Pharmacies Market by Region
• 6.2 Global Hospital Pharmacies Market by Region
• 6.3 Global Online Pharmacies Market by Region

Chapter 7. Global Anxiety Disorders And Depression Treatment Market by Region

• 7.1 North America Anxiety Disorders And Depression Treatment Market
  • 7.1.1 North America Anxiety Disorders And Depression Treatment Market by Indication
    • 7.1.1.1 North America Anxiety Market by Country
    • 7.1.1.2 North America Depression Market by Country
  • 7.1.2 North America Anxiety Disorders And Depression Treatment Market by Drugs
    • 7.1.2.1 North America Antidepressants Market by Country
    • 7.1.2.2 North America Anxiolytics Market by Country
    • 7.1.2.3 North America Anticonvulsants Market by Country
    • 7.1.2.4 North America Noradrenergic Agents Market by Country
    • 7.1.2.5 North America Atypical Antipsychotics Market by Country
  • 7.1.3 North America Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.1.3.1 North America Retail Pharmacies Market by Country
    • 7.1.3.2 North America Hospital Pharmacies Market by Country
    • 7.1.3.3 North America Online Pharmacies Market by Country
  • 7.1.4 North America Anxiety Disorders And Depression Treatment Market by Country
    • 7.1.4.1 US Anxiety Disorders And Depression Treatment Market
      • 7.1.4.1.1 US Anxiety Disorders And Depression Treatment Market by Indication
      • 7.1.4.1.2 US Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.1.4.1.3 US Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.1.4.2 Canada Anxiety Disorders And Depression Treatment Market
      • 7.1.4.2.1 Canada Anxiety Disorders And Depression Treatment Market by Indication
      • 7.1.4.2.2 Canada Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.1.4.2.3 Canada Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.1.4.3 Mexico Anxiety Disorders And Depression Treatment Market
      • 7.1.4.3.1 Mexico Anxiety Disorders And Depression Treatment Market by Indication
      • 7.1.4.3.2 Mexico Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.1.4.3.3 Mexico Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.1.4.4 Rest of North America Anxiety Disorders And Depression Treatment Market
      • 7.1.4.4.1 Rest of North America Anxiety Disorders And Depression Treatment Market by Indication
      • 7.1.4.4.2 Rest of North America Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.1.4.4.3 Rest of North America Anxiety Disorders And Depression Treatment Market by Distribution Channel
• 7.2 Europe Anxiety Disorders And Depression Treatment Market
  • 7.2.1 Europe Anxiety Disorders And Depression Treatment Market by Indication
    • 7.2.1.1 Europe Anxiety Market by Country
    • 7.2.1.2 Europe Depression Market by Country
  • 7.2.2 Europe Anxiety Disorders And Depression Treatment Market by Drugs
    • 7.2.2.1 Europe Antidepressants Market by Country
    • 7.2.2.2 Europe Anxiolytics Market by Country
    • 7.2.2.3 Europe Anticonvulsants Market by Country
    • 7.2.2.4 Europe Noradrenergic Agents Market by Country
    • 7.2.2.5 Europe Atypical Antipsychotics Market by Country
  • 7.2.3 Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.2.3.1 Europe Retail Pharmacies Market by Country
    • 7.2.3.2 Europe Hospital Pharmacies Market by Country
    • 7.2.3.3 Europe Online Pharmacies Market by Country
  • 7.2.4 Europe Anxiety Disorders And Depression Treatment Market by Country
    • 7.2.4.1 Germany Anxiety Disorders And Depression Treatment Market
      • 7.2.4.1.1 Germany Anxiety Disorders And Depression Treatment Market by Indication
      • 7.2.4.1.2 Germany Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.2.4.1.3 Germany Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.2.4.2 UK Anxiety Disorders And Depression Treatment Market
      • 7.2.4.2.1 UK Anxiety Disorders And Depression Treatment Market by Indication
      • 7.2.4.2.2 UK Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.2.4.2.3 UK Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.2.4.3 France Anxiety Disorders And Depression Treatment Market
      • 7.2.4.3.1 France Anxiety Disorders And Depression Treatment Market by Indication
      • 7.2.4.3.2 France Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.2.4.3.3 France Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.2.4.4 Russia Anxiety Disorders And Depression Treatment Market
      • 7.2.4.4.1 Russia Anxiety Disorders And Depression Treatment Market by Indication
      • 7.2.4.4.2 Russia Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.2.4.4.3 Russia Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.2.4.5 Spain Anxiety Disorders And Depression Treatment Market
      • 7.2.4.5.1 Spain Anxiety Disorders And Depression Treatment Market by Indication
      • 7.2.4.5.2 Spain Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.2.4.5.3 Spain Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.2.4.6 Italy Anxiety Disorders And Depression Treatment Market
      • 7.2.4.6.1 Italy Anxiety Disorders And Depression Treatment Market by Indication
      • 7.2.4.6.2 Italy Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.2.4.6.3 Italy Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.2.4.7 Rest of Europe Anxiety Disorders And Depression Treatment Market
      • 7.2.4.7.1 Rest of Europe Anxiety Disorders And Depression Treatment Market by Indication
      • 7.2.4.7.2 Rest of Europe Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.2.4.7.3 Rest of Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel
• 7.3 Asia Pacific Anxiety Disorders And Depression Treatment Market
  • 7.3.1 Asia Pacific Anxiety Disorders And Depression Treatment Market by Indication
    • 7.3.1.1 Asia Pacific Anxiety Market by Country
    • 7.3.1.2 Asia Pacific Depression Market by Country
  • 7.3.2 Asia Pacific Anxiety Disorders And Depression Treatment Market by Drugs
    • 7.3.2.1 Asia Pacific Antidepressants Market by Country
    • 7.3.2.2 Asia Pacific Anxiolytics Market by Country
    • 7.3.2.3 Asia Pacific Anticonvulsants Market by Country
    • 7.3.2.4 Asia Pacific Noradrenergic Agents Market by Country
    • 7.3.2.5 Asia Pacific Atypical Antipsychotics Market by Country
  • 7.3.3 Asia Pacific Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.3.3.1 Asia Pacific Retail Pharmacies Market by Country
    • 7.3.3.2 Asia Pacific Hospital Pharmacies Market by Country
    • 7.3.3.3 Asia Pacific Online Pharmacies Market by Country
  • 7.3.4 Asia Pacific Anxiety Disorders And Depression Treatment Market by Country
    • 7.3.4.1 China Anxiety Disorders And Depression Treatment Market
      • 7.3.4.1.1 China Anxiety Disorders And Depression Treatment Market by Indication
      • 7.3.4.1.2 China Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.3.4.1.3 China Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.3.4.2 Japan Anxiety Disorders And Depression Treatment Market
      • 7.3.4.2.1 Japan Anxiety Disorders And Depression Treatment Market by Indication
      • 7.3.4.2.2 Japan Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.3.4.2.3 Japan Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.3.4.3 India Anxiety Disorders And Depression Treatment Market
      • 7.3.4.3.1 India Anxiety Disorders And Depression Treatment Market by Indication
      • 7.3.4.3.2 India Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.3.4.3.3 India Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.3.4.4 South Korea Anxiety Disorders And Depression Treatment Market
      • 7.3.4.4.1 South Korea Anxiety Disorders And Depression Treatment Market by Indication
      • 7.3.4.4.2 South Korea Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.3.4.4.3 South Korea Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.3.4.5 Singapore Anxiety Disorders And Depression Treatment Market
      • 7.3.4.5.1 Singapore Anxiety Disorders And Depression Treatment Market by Indication
      • 7.3.4.5.2 Singapore Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.3.4.5.3 Singapore Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.3.4.6 Malaysia Anxiety Disorders And Depression Treatment Market
      • 7.3.4.6.1 Malaysia Anxiety Disorders And Depression Treatment Market by Indication
      • 7.3.4.6.2 Malaysia Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.3.4.6.3 Malaysia Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.3.4.7 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market
      • 7.3.4.7.1 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Indication
      • 7.3.4.7.2 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.3.4.7.3 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Distribution Channel
• 7.4 LAMEA Anxiety Disorders And Depression Treatment Market
  • 7.4.1 LAMEA Anxiety Disorders And Depression Treatment Market by Indication
    • 7.4.1.1 LAMEA Anxiety Market by Country
    • 7.4.1.2 LAMEA Depression Market by Country
  • 7.4.2 LAMEA Anxiety Disorders And Depression Treatment Market by Drugs
    • 7.4.2.1 LAMEA Antidepressants Market by Country
    • 7.4.2.2 LAMEA Anxiolytics Market by Country
    • 7.4.2.3 LAMEA Anticonvulsants Market by Country
    • 7.4.2.4 LAMEA Noradrenergic Agents Market by Country
    • 7.4.2.5 LAMEA Atypical Antipsychotics Market by Country
  • 7.4.3 LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.4.3.1 LAMEA Retail Pharmacies Market by Country
    • 7.4.3.2 LAMEA Hospital Pharmacies Market by Country
    • 7.4.3.3 LAMEA Online Pharmacies Market by Country
  • 7.4.4 LAMEA Anxiety Disorders And Depression Treatment Market by Country
    • 7.4.4.1 Brazil Anxiety Disorders And Depression Treatment Market
      • 7.4.4.1.1 Brazil Anxiety Disorders And Depression Treatment Market by Indication
      • 7.4.4.1.2 Brazil Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.4.4.1.3 Brazil Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.4.4.2 Argentina Anxiety Disorders And Depression Treatment Market
      • 7.4.4.2.1 Argentina Anxiety Disorders And Depression Treatment Market by Indication
      • 7.4.4.2.2 Argentina Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.4.4.2.3 Argentina Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.4.4.3 UAE Anxiety Disorders And Depression Treatment Market
      • 7.4.4.3.1 UAE Anxiety Disorders And Depression Treatment Market by Indication
      • 7.4.4.3.2 UAE Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.4.4.3.3 UAE Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.4.4.4 Saudi Arabia Anxiety Disorders And Depression Treatment Market
      • 7.4.4.4.1 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Indication
      • 7.4.4.4.2 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.4.4.4.3 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.4.4.5 South Africa Anxiety Disorders And Depression Treatment Market
      • 7.4.4.5.1 South Africa Anxiety Disorders And Depression Treatment Market by Indication
      • 7.4.4.5.2 South Africa Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.4.4.5.3 South Africa Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.4.4.6 Nigeria Anxiety Disorders And Depression Treatment Market
      • 7.4.4.6.1 Nigeria Anxiety Disorders And Depression Treatment Market by Indication
      • 7.4.4.6.2 Nigeria Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.4.4.6.3 Nigeria Anxiety Disorders And Depression Treatment Market by Distribution Channel
    • 7.4.4.7 Rest of LAMEA Anxiety Disorders And Depression Treatment Market
      • 7.4.4.7.1 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Indication
      • 7.4.4.7.2 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Drugs
      • 7.4.4.7.3 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel

Chapter 8. Company Profiles

• 8.1 Pfizer, Inc.
  • 8.1.1 Company Overview
  • 8.1.2 Financial Analysis
  • 8.1.3 Regional & Segmental Analysis
  • 8.1.4 Research & Development Expense
  • 8.1.5 SWOT Analysis
• 8.2 GlaxoSmithKline PLC (GSK)
  • 8.2.1 Company Overview
  • 8.2.2 Financial Analysis
  • 8.2.3 Regional Analysis
  • 8.2.4 Research & Development Expense
  • 8.2.5 SWOT Analysis
• 8.3 Merck & Co., Inc.
  • 8.3.1 Company Overview
  • 8.3.2 Financial Analysis
  • 8.3.3 Segmental and Regional Analysis
  • 8.3.4 Research & Development Expenses
  • 8.3.5 SWOT Analysis
• 8.4 Eli Lilly And Company
  • 8.4.1 Company Overview
  • 8.4.2 Financial Analysis
  • 8.4.3 Regional Analysis
  • 8.4.4 Research & Development Expenses
  • 8.4.5 SWOT Analysis
• 8.5 AstraZeneca PLC
  • 8.5.1 Company Overview
  • 8.5.2 Financial Analysis
  • 8.5.3 Regional Analysis
  • 8.5.4 Research & Development Expenses
  • 8.5.5 SWOT Analysis
• 8.6 Bristol-Myers Squibb Company
  • 8.6.1 Company Overview
  • 8.6.2 Financial Analysis
  • 8.6.3 Regional Analysis
  • 8.6.4 Research & Development Expenses
  • 8.6.5 SWOT Analysis
• 8.7 Johnson & Johnson
  • 8.7.1 Company Overview
  • 8.7.2 Financial Analysis
  • 8.7.3 Segmental & Regional Analysis
  • 8.7.4 Research & Development Expenses
  • 8.7.5 SWOT Analysis
• 8.8 AbbVie, Inc.
  • 8.8.1 Company Overview
  • 8.8.2 Financial Analysis
  • 8.8.3 Regional Analysis
  • 8.8.4 Research & Development Expense
  • 8.8.5 SWOT Analysis
• 8.9 Sanofi S.A.
  • 8.9.1 Company Overview
  • 8.9.2 Financial Analysis
  • 8.9.3 Segmental and Regional Analysis
  • 8.9.4 Research & Development Expense
  • 8.9.5 SWOT Analysis
• 8.10. Takeda Pharmaceutical Company Limited
  • 8.10.1 Company Overview
  • 8.10.2 Financial Analysis
  • 8.10.3 Regional Analysis
  • 8.10.4 Research & Development Expense
  • 8.10.5 SWOT Analysis

Chapter 9. Winning Imperatives for Anxiety Disorders and Depression Treatment Market